Causes of late renal allograft loss: Chronic allograft dysfunction, death, and other factors

Transplantation

Volumn 71, Issue 11 SUPPL., 2001, Pages

  Kreis, H A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CADAVER DONOR; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONFERENCE PAPER; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; PATHOGENESIS; PRIORITY JOURNAL;

CHRONIC DISEASE; CYCLOSPORINE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035876504     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. Patient, graft, and functional survival rates: An overview
2. The UNOS scientific renal transplant registry
3. Improved graft survival after renal transplantation in the United States, 1988 to 1996
4. ®) - An analysis at 10 years
5. Factors contributing to long-term kidney graft survival in eurotransplant
6. Randomized study with cyclosporine in kidney transplantation: 10 Year follow-up
7. ®) in cadaveric renal transplantation. Ten-year follow-up of a multicentre trial
8. Chronic rejection: An update on the mechanism
9. Chronic rejection
10. Renal transplantation: Current status, complications and prevention
11. The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection
12. Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants: Joint proposal from the fourth Alexis Carrel conference on chronic rejection and accelerated arteriosclerosis in transplanted organs
13. Histopathology of calcineurin inhibitor-induced nephrotoxicity
14. Unique changes in interstitial extracellular matrix composition are associated with rejection and cyclosporine toxicity in human renal allograft biopsies
15. Diagnosis of chronic rejection using peritubular and glomerular capillary lesions
16. Chronic allograft dysfunction: Mechanisms and new approaches to therapy
17. Predictors of chronic rejection in renal transplant recipients
18. Clinical correlates of chronic rejection in pediatric renal transplantation. A report of the North American pediatric renal transplant cooperative study
19. Acute rejection is a major risk factor for chronic rejection
20. The impact of an acute rejection episode on long-term renal allograft survival (t1/2)
21. Long-term renal allograft survival
22. Early versus late acute renal allograft rejection: Impact on chronic rejection
23. Identification of clinical and histopathologic risk factors for diminished renal function 2 years posttransplant
24. Renal transplant fibrosis: Histomorphometric assessment of early renal transplant biopsies for markers of chronic rejection
25. Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients
26. Histological findings in early routine biopsies of stable renal allograft recipients
27. Beneficial effects of treatment of early subclinical rejection: A randomized study
28. The clinical impact of nephrotoxicity in renal transplantation
29. Management strategies for nephrotoxicity
30. Risk factors in renal transplantation and implications for immunosuppressive therapy
31. Quantitation of allograft fibrosis and chronic allograft nephropathy
32. Chronic rejection: Increasing evidence for the importance of allogen-independent factors
33. Organ transplantation in the twenty-first century
34. Ischemic heart disease - Major cause of death and graft loss after renal transplantation in Scandinavia
35. Early echocardiographic changes and survival following renal transplantation
36. Pre-operative echocardiographic abnormalities and adverse outcome following renal transplantation
37. Cardiovascular disease after renal transplantation
38. Patient survival after renal transplantation: II. The impact of smoking
39. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure
40. Cardiovascular morbidity and risk factors in renal transplant patients
41. Risk factors for accelerated atherosclerosis in renal transplant recipients
42. Hypertension after transplantation
43. Hypertension is associated with hyperlipidemia, coronary heart disease and chronic graft failure in kidney transplant recipients
44. Association of chronic kidney graft failure with recipient blood pressure
45. Treatment of hypertension in renal allograft patients: Does drug selection make a difference?
46. Incidence and long-term cost of steroid-related side effects after renal transplantation
47. Risk for posttransplant diabetes mellitus with current immunosuppressive medications
48. The side-effects of ciclosporine-A and tacrolimus
49. Sirolimus (rapamycin)-based therapy in human renal transplantation: Similar efficacy and different toxicity compared with cyclosporine
50. Rapamune (RAPA, rapamycin, sirolimus): Mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression